• Ready-to-Use Models. Faster Immunotherapy Research. | Save Up to 25%

    Learn More
Primary Cells

Human Umbilical Vein Endothelial Cells, Neonatal

  • For research use only

Cat No.

ABC-TC3853

Product Type

Vascular Cells

Cell Type

Endothelial

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Umbilical Vein

Disease

Normal

Storage

Liquid Nitrogen

Human Umbilical Vein Endothelial Cells (HUVEC) are isolated from normal human umbilical vein.

Product Image

Description

Human Umbilical Vein Endothelial Cells, Neonatal are primary cells isolated from the umbilical vein of newborns. These cells exhibit a classic endothelial morphology and play a critical role in vascular homeostasis, regulating processes such as angiogenesis, vascular permeability, and immune response through the secretion of cytokines and nitric oxide (NO). These cells are characterized by high expression of CD31. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.

Product Code

Human Umbilical Vein Endothelial Cells, Neonatal, HUVECs, Neonatal Umbilical Vein ECs, Primary Umbilical Vein Endothelial Cells

Species

Human

Cat.No

ABC-TC3853

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Endothelial

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Umbilical Vein

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Vascular Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Umbilical Vein Endothelial Cells, Neonatal are extensively utilized in biomedical research due to their relevance in vascular physiology and pathology. They serve as an in vitro model for studying endothelial barrier function, angiogenesis, and inflammatory responses, making them indispensable in cardiovascular and cancer research. In drug development, they are employed to assess the efficacy and toxicity of novel compounds targeting endothelial dysfunction, such as anti-angiogenic therapies for cancer or vasoprotective agents for atherosclerosis.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Umbilical Vein Endothelial Cells, Neonatal

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button